Join Us at NCHCMM 2025 – Registration Now Open!
Public health communicators, mark your calendars! The 2025 National Conference on Health Communication, Marketing & Media (NCHCMM) is set for July 28-30 at the Hyatt Regency Atlanta. This premier event brings together experts to explore innovative strategies in health communication. The first keynote speaker, Dr. Garth Graham—cardiologist, researcher, and Head of YouTube Health—promises val…
New Ethical AI Guidelines: A Must-Read for Public Health Communicators
Artificial Intelligence is reshaping public health communication, and NPHIC has proudly contributed to a groundbreaking new resource: the Guidelines for the Ethical Use of AI in Public Health Communications. Developed by a diverse working group of public health and technology leaders, this initiative ensures AI is used responsibly while upholding accuracy, transparency, and equity.
Executive…
NPHIC’s Robert Jennings Featured on Public Health Review Morning Edition Podcast
Robert Jennings, Executive Director of the National Public Health Information Coalition (NPHIC), is shaping the future of public health communication by developing guidelines for AI use in the field. In a recent Public Health Review Morning Edition episode, Jennings highlighted the need for responsible AI integration to enhance messaging and outreach. He also provided an outlook on evolving com…
Stay Connected with NPHIC on Social Media
NPHIC members, stay informed and engaged by following us on Facebook (@NPHICpublic), Twitter (X) (@NPHIC), and Instagram (@NPHIC_). We’re excited to highlight our new LinkedIn page, where you can find important updates on the National Conference on Health Communication, Marketing, and Media (NCHCMM). Follow us at NPHIC on LinkedIn.
We also invite you to join our exclusive closed Facebook group for members, a space for collaboration and sharing valuable information. Strengthen our community and amplify the impact of public health communications by joining today: NPHIC Member-Only Fa…
U.S. Pays $590 Million to Moderna to Speed up Development of Bird Flu Vaccine
The U.S. Department of Health and Human Services has committed $590 million to Moderna to accelerate the development of a bird flu vaccine. This effort builds on $176 million awarded last year and aims to advance late-stage development, clinical studies, and licensure of a "pandemic influenza vaccine" targeting H5N1 and other influenza subtypes.
With bird flu rapidly spreading among livestock and mammals, and 67 confirmed human cases—including one death—public health officials emphasize the unpredictability of the virus. The CDC recently issued an alert urging hospitals to prioriti…